Earnings Feed
Start Free
Home/Filings/4/0001140361-12-025912
4//SEC Filing

Cooper Jeffrey H 4

Accession 0001140361-12-025912

CIK 0001048477other
View on SEC.govCompany Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 7:30 PM ET

Size

18.4 KB

Accession

0001140361-12-025912

Insider Transaction Report

Form 4
Period: 2012-04-30
BIOMARIN PHARMACEUTICAL INCBMRN
Cooper Jeffrey H
SVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2012-05-14$21.51/sh+6,500$139,815→ 62,589 total
  • Sale

    Common Stock

    2012-05-14$38.09/sh−25,250$961,717→ 41,089 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-05-14$26.49/sh−15,000$397,350→ 164,042 total
    Exercise: $26.49From: 2011-11-12Exp: 2021-05-11→ Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-05-14$26.49/sh+15,000$397,350→ 56,089 total
  • Award

    Common Stock

    2012-04-30$19.35/sh+985$19,056→ 41,089 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-05-14$21.51/sh−6,500$139,815→ 157,542 total
    Exercise: $21.51From: 2010-11-12Exp: 2020-05-11→ Common Stock (6,500 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-05-14$14.39/sh−3,750$53,963→ 153,792 total
    Exercise: $14.39From: 2009-11-12Exp: 2019-05-11→ Common Stock (3,750 underlying)
  • Exercise/Conversion

    Common Stock

    2012-05-14$14.39/sh+3,750$53,963→ 66,339 total
Footnotes (6)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP period of November 1,2011 to April 30, 2012.
  • [F2]Transaction made pursuant to a Rule 10b5-1 Trading plan executed March 6, 2012.
  • [F3]The price in Column 4 is a weighted average price. The prices actually received ranged from $37.31 to $38.6325. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]Original option grant vested 6/48ths on November 12, 2011 and 1/48th on the 12th of every month thereafter.
  • [F5]Original option grant vested 6/48ths on November 12, 2010 and 1/48th on the 12th of every month thereafter.
  • [F6]Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.

Documents

1 file

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

→
Entity typeother

Related Parties

1
  • filerCIK 0001301173

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:30 PM ET
Size
18.4 KB
View on SEC.gov